|
|
||||||||
1 Weis Center for Research and 2 Department of Medicine, Geisinger Medical Center, Danville, Pennsylvania 17822
| |
ABSTRACT |
|---|
|
|
|---|
Previous studies have shown that overexpression of phospholemman (PLM) affected contractile function and Ca2+ homeostasis in adult rat myocytes. We tested the hypothesis that PLM modulated Na+/Ca2+ exchanger (NCX1) activity. PLM was overexpressed in adult rat myocytes by adenovirus-mediated gene transfer. After 72 h, the half-time of relaxation from caffeine-induced contracture, an estimate of forward NCX1 activity, was prolonged 1.8-fold (P < 0.003) in myocytes overexpressing PLM compared with control myocytes overexpressing green fluorescent protein alone. Reverse NCX1 current (3 Na+ out:1 Ca2+ in) was significantly (P < 0.0001) lower in PLM myocytes, especially at more positive voltages. Immunofluorescence demonstrated colocalization of PLM and NCX1 to the plasma membrane and t-tubules. Resting membrane potential, action potential amplitude and duration, myocyte size, and NCX1 and calsequestrin protein levels were not affected by PLM overexpression. At 5 mM extracellular [Ca2+] ([Ca2+]o), the depressed contraction amplitudes in PLM myocytes were increased towards normal by cooverexpression with NCX1. At 0.6 mM [Ca2+]o, the supranormal contraction amplitudes in PLM myocytes were reduced by cooverexpression with NCX1. We conclude that PLM modulated myocyte contractility partly by inhibiting Na+/Ca2+ exchange.
primary cardiac myocyte culture; excitation-contraction coupling; edge detection; patch clamp
| |
INTRODUCTION |
|---|
|
|
|---|
PHOSPHOLEMMAN (PLM) is a 72-amino acid membrane phosphoprotein with a single transmembrane domain. In heart and skeletal muscle, PLM is phosphorylated in response to adrenergic (16, 22) and insulin (30) stimulation. PLM is also a substrate for myotonic dystrophy protein kinase (19). The physiological function of PLM in the heart is largely unknown except that PLM phosphorylation in response to adrenergic stimulation paralleled the positive inotropic effects (22) and that expression of PLM increased twofold in postinfarction rat hearts (25). In a previous study, we (27) have demonstrated that PLM overexpression in adult rat myocytes resulted in altered contractility and cytosolic Ca2+ concentration ([Ca2+]i) transients. Specifically, at low extracellular [Ca2+] ([Ca2+]o; 0.6 mM), both contraction and [Ca2+]i transient amplitudes were larger in myocytes overexpressing PLM. At high [Ca2+]o (5 mM), cell shortening and [Ca2+]i transient amplitudes were reduced in myocytes overexpressing PLM. This pattern of contractile and [Ca2+]i transient abnormalities observed in myocytes overexpressing PLM mimics that observed in postinfarction rat myocytes (3, 31), in which Na+/Ca2+ exchanger (NCX1) activity has been shown to be depressed (6, 33). In addition, downregulation of NCX1 in rat myocytes by adenovirus (Adv)-mediated antisense transfer resulted in a pattern of contraction and [Ca2+]i transient abnormalities (29) similar to that observed in myocytes overexpressing PLM (27). Finally, the pattern of [Ca2+]i transient and contraction abnormalities in myocytes overexpressing PLM (27) was opposite to that observed in myocytes in which NCX1 activity was enhanced by overexpression (32). These observations strongly suggest, but do not prove, that PLM affects cardiac myocyte contractility by modulating Na+/Ca2+ exchange activity. The present study was undertaken to test the hypothesis that PLM directly affects Na+/Ca2+ exchange activity in rat cardiac myocytes.
| |
METHODS |
|---|
|
|
|---|
Myocyte isolation and culture. Cardiac myocytes were isolated from the septum and left ventricular free wall of male Sprague-Dawley rats (~280 g) by successive perfusion with collagenase and hyaluronidase (4). Isolated myocytes were either seeded on laminin-coated coverslips, which were subsequently placed in four-well trays (Nuclone), or placed directly on laminin-coated four-well trays. Culture medium consisted of serum-free media 199 (Earle's salts without L-glutamine and NaHCO3) supplemented with (in mM) 25 NaHCO3, 5 creatine, 5 taurine, 2 carnitine, and 0.1 ascorbic acid. Insulin (100 U/ml), 5-bromo-2-deoxyuridine (31 µg/ml), bovine serum albumin (0.2%), penicillin (500 U/ml), and gentamicin (4 µg/ml) were also added to the culture medium. After 2 h, media were changed to remove nonadherent myocytes. The myocytes were incubated for an additional 3-4 h before initiation of electrical stimulation. Myocytes were electrically paced in culture (1 Hz, [Ca2+]o = 1.8 mM) as previously described (32). Culture media were changed daily over the course of the experiments. Under continuous pacing culture conditions, we have (27) previously demonstrated that myocyte contractility did not decline for at least 72 h.
Adenoviral infection of cardiac myocytes. Recombinant, replication-deficient Adv expressing either green fluorescent protein (GFP) alone, GFP and PLM (27), or GFP and NCX1 (32) were constructed as described previously. Two hours after isolation, myocytes seeded in four-well trays were infected with Adv-GFP, Adv-GFP-PLM, or Adv-GFP-NCX1 plus Adv-GFP-PLM at a multiplicity of infection of 2 for 3 h. Media were then changed, and myocytes were studied after 72 h in continued pacing culture. We have previously demonstrated that over 95% of myocytes were successfully infected (32) and that adenoviral infection of myocytes had no effects on myocyte contractility when examined after 72 h of continuous pacing culture (27). We have also previously shown that the effects of PLM overexpression on contractility and [Ca2+]i transients were manifest 72 h after Adv-PLM infection (27). For the sake of brevity, myocytes infected with Adv-GFP, Adv-GFP-PLM, and Adv-GFP-NCX1 plus Adv-GFP-PLM are referred to as GFP, PLM, and PLM-NCX1 myocytes, respectively.
Myocyte shortening measurements. Myocyte adherent to the coverslips were bathed in 0.6 ml of air- and temperature (37°C)-equilibrated, HEPES-buffered (20 mM, pH 7.4) media 199 containing either 0.6 or 5.0 mM [Ca2+]o and were placed on a temperature-controlled stage (37°C) of a Zeiss IM35 microscope. Measurements of myocyte contraction (1 Hz) were performed as previously described (27, 29, 31, 32).
Caffeine-induced contractures. Myocytes bathed in 5.0 mM [Ca2+]o were paced at 1 Hz. At 200 ms after the 21st beat, a trigger TTL pulse of 2.4-s duration was generated by a programmable multichannel stimulator (STIM-6, Ionoptix; Milton, MA) to initiate caffeine (5 mM) application by puffer (Ionoptix) superfusion, which allowed rapid solution changes around a single cell (29, 31-33). The caffeine-induced contracture and subsequent relaxation were captured by a charge-coupled device videocamera (Ionoptix) and analyzed (29, 31).
Na+/Ca2+
exchange current measurements.
Whole cell patch-clamp recordings were performed at 30°C as described
previously (29, 33, 34). Briefly, fire-polished pipettes
(tip diameter 4-6 µm) with resistances of 0.8-1.4 M
when
filled with standard internal solution were used. To facilitate reverse-mode operation of NCX1, pipettes were filled with a nominally Ca2+-free solution containing (in mM) 100 Cs+
glutamate, 7.25 NaCl, 1 MgCl2, 20 HEPES, and 2.5 Na2 ATP; pH 7.2. EGTA was normally not included in the
pipette filling solution. Free Ca2+ in the EGTA-free
pipette solution was 187 nM, measured fluorimetrically with fura 2. In
another series of experiments, EGTA (10 mM) and CaCl2 (6 mM) were added to the pipette filling solution such that free
Ca2+ was "clamped" at 205 nM (verified
fluorimetrically). To maintain similar osmolarities between
EGTA-containing and EGTA-free pipette solutions, Cs+
glutamate was reduced from 100 to 80 mM in EGTA-containing solutions.
70 to
40 mV to inactivate the fast inward Na+ current
(33). Eleven conditioning pulses (from
40 to 0 mV, 300 ms, 1 Hz) were delivered before the arrival of each test pulse (between
30 to +70 mV, 10-mV increments, 1,000 ms). After the last test pulse
at +70 mV, the myocyte was held at
40 mV for 100 ms before being
returned to a holding potential of
70 mV. We have previously shown
that the steady-state outward currents measured under these conditions
were reverse Na+/Ca2+ exchange current
(INaCa) (33). Currents were
filtered at 2 kHz, and data were acquired at 2 kHz. Leak-subtracted
INaCa were averaged from 700 to 1,000 ms of the
test pulse. Whole cell capacitance (Cm) for each
myocyte was measured by applying a small hyperpolarizing pulse (
10
mV, 16 ms) and integrating the resulting current change (digitized at
50 kHz, 0.5-kHz filter) over time. To facilitate comparison of
INaCa among cells, INaCa
of each myocyte was divided by its Cm to account
for variations in cell sizes.
Action potential measurements. Action potentials (APs) from GFP and PLM myocytes were recorded after 72 h of continual pacing culture using the current-clamp configuration at 1.5 times the threshold stimulus and 4-ms duration (29, 34). Pipette solution consisted of (in mM) 125 KCl, 4 MgCl2, 0.06 CaCl2, 10 HEPES, 5 potassium EGTA, 3.1 Na2 ATP, and 5 Na2-creatine phosphate; pH 7.2. External solution consisted of (in mM) 132 NaCl, 5.4 KCl, 1.8 CaCl2, 1.8 MgCl2, 0.6 NaH2PO4, 15 HEPES, and 5 glucose; pH 7.4.
NCX1, PLM, and calsequestrin immunoblotting.
Cultured myocytes were harvested for immunoblotting on day
3. Cultured myocytes in a four-well tray were rinsed three times with ice-cold PBS. They were then scraped into 1 ml of ice-cold lysis
buffer containing (in mM) 50 Tris (pH 8.0), 150 NaCl, 1 Na+
orthovanadate, 1 PMSF, 100 NaF, 1 EDTA, and 1 EGTA, and 0.5% NP-40, 10 µg/ml leupeptin, and 10 µg/ml aprotinin. The cell lysate was snap
frozen with dry ice-ethanol and stored at
80°C.
Immunolocalization of PLM and NCX1 in adult rat cardiac myocytes. Freshly isolated rat cardiac myocytes were plated on laminin-coated glass slide chambers (Nunc, Lab-Tek Division; Naperville, IL) and allowed to adhere for 2 h. Adherent myocytes were chilled on ice and rinsed three times with ice-cold PBS containing 2 mM EGTA. Myocytes were fixed for 30 min on ice in cold 3% paraformaldehyde in PBS with 2 mM EGTA. After two rinses with ice-cold PBS, cells were permeabilized for 2 min in cold 0.05% Triton X-100. Permeabilized myocytes were rinsed two times with PBS and one time with BLOTTO (5% nonfat dry milk, 0.1 M NaCl, and 50 mM Tris · HCl; pH 7.4). Primary antibodies against NCX1 (1:100, R3F1, mouse monoclonal) and PLM (1:100, rabbit polyclonal) diluted in BLOTTO were added to the cells, incubated at room temperature in the dark for 60 min, and rinsed three times with BLOTTO. Secondary antibodies (1:200, see below) diluted in BLOTTO were added to cells that were incubated in the dark for 30 min, followed by three PBS rinses. The slide was then removed from the chamber, and a coverslip containing mounting solution (90% glycerol in PBS + p-phenylaminediamine) was applied. Myocytes were viewed with a Nikon Optiphot-2 microscope equipped for epifluorescence. Images were acquired with an air-cooled charge-coupled device SenSys digital camera (Photometrics; Tucson, AZ) and processed using IPLab and Enhanced Photon Reassignment software (Scanalytics; Fairfax, VA). Secondary antibodies used were as follows: goat anti-rabbit IgG conjugated with Texas red-X (Molecular Probes; Eugene, OR), goat anti-mouse IgG coupled to FITC (Sigma; St. Louis, MO), donkey anti-mouse IgG conjugated with Texas red, and donkey anti-rabbit IgG coupled to FITC (Jackson ImmunoResearch; West Grove, PA).
Statistics. All results are expressed as means ± SE. For analysis of INaCa as a function of group (GFP vs. PLM) and test voltage, two-way ANOVA was used to determine statistical significance. For analysis of contraction amplitudes as a function of group (GFP vs. PLM vs. PLM-NCX1) and [Ca2+]o, two-way ANOVA was used. For analysis of AP parameters, caffeine contracture relaxation, and protein abundance, Student's t-test was used. A commercial software package (JMP version 4, SAS Institutes; Cary, NC) was used in all statistical analyses. In all analyses, P < 0.05 was taken to be statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Effects of PLM overexpression on relaxation from
caffeine-induced contractures.
After steady-state twitch amplitude was achieved, application of
5 mM caffeine to a myocyte at end diastole caused a large contracture
due to sarcoplasmic reticulum (SR) Ca2+ release and then
relaxation to a shorter resting cell length in the continued presence
of caffeine (Fig. 1). The incomplete relaxation is thought to be due to increased myofilament sensitivity to
Ca2+ by caffeine. Relaxation in the continued presence of
caffeine was mediated primarily by forward
Na+/Ca2+ exchange, because SR Ca2+
accumulation was inhibited (33). The half-time of
relaxation from caffeine-induced contracture was significantly
(P < 0.003) slower in PLM (2.90 ± 0.29s,
n = 11) than GFP (1.68 ± 0.23s, n = 14) myocytes (Fig. 1), suggesting reduced forward
Na+/Ca2+ exchange activity in PLM myocytes.
|
Effects of PLM overexpression on reverse INaCa and cell
size in adult rat myocytes.
Figure 2 shows the steady-state reverse
INaCa measured at various membrane potentials,
at 30°C and 5.0 mM [Ca2+]o, in both GFP
(open symbols; n = 17) and PLM (filled symbols; n = 16) myocytes in which
[Ca2+]i (187 nM) was not buffered. It can be
appreciated that the absolute magnitudes of
INaCa were in general lower in PLM than GFP
myocytes. Two-way ANOVA confirmed a significant group (PLM vs. GFP)
effect (P < 0.0003). In both GFP and PLM myocytes,
depolarization to more positive membrane potentials increased the
absolute magnitude of INaCa (voltage effect,
P < 0.0001). In addition, the differences in
INaCa between GFP and PLM myocytes were
amplified at more positive membrane voltages (group × voltage
interaction effect, P < 0.0001).
|
Effects of PLM overexpression on AP.
Changes in INaCa in PLM myocytes may potentially
affect AP amplitude and duration. Therefore, we measured AP in GFP and
PLM myocytes (Fig. 3). Resting membrane
potential (RMP), AP amplitude, and AP duration at 50% repolarization
measured in GFP myocytes (Fig. 3 and Table
1) were similar to those reported for
adult rat myocytes cultured in serum-free media for 72 h
(7). There were no significant differences in RMP,
AP amplitude, and AP duration at 50% and 90% repolarization between
GFP and PLM myocytes (Fig. 3 and Table 1), indicating that PLM
overexpression had no effect on myocyte RMP and AP morphology.
|
|
Cooverexpression of NCX1 corrects contractile abnormalities in PLM
myocytes.
We have previously shown (27) that compared with GFP
myocytes, maximal cell shortening amplitudes measured at 0.6 mM
[Ca2+]o were higher but those measured at 5 mM [Ca2+]o were lower in PLM myocytes. We
have confirmed this finding in the present study (Fig. 4,
A-D, and Table
2). More importantly, in myocytes in
which both PLM and NCX1 were overexpressed (Fig. 5), maximal shortening amplitudes at 5 mM
[Ca2+]o were increased toward control GFP
myocyte levels (Fig. 4, B, D, and F,
and Table 2). At 0.6 mM [Ca2+]o, the
supranormal contraction amplitudes of PLM myocytes (Fig. 4C)
were reduced toward control GFP levels (Fig. 4A) by
cooverexpression with NCX1 (Fig. 4E) (Table 2). In all three
groups, increasing [Ca2+]o increased maximal
contraction amplitudes (Table 2). These conclusions are supported by
highly significant (P < 0.0001)
[Ca2+]o and group × [Ca2+]o interaction effects in maximal
contraction amplitudes between GFP and PLM myocytes, indicating the
magnitude and/or direction of the effects of
[Ca2+]o on cell shortening was different
between GFP and PLM myocytes. Likewise, comparison between PLM and
PLM-NCX1 myocytes demonstrated significant (P
0.0001)
[Ca2+]o and group × [Ca2+]o interaction effects. By contrast,
there were no significant (P > 0.12) group × [Ca2+]o interaction effects between GFP and
PLM-NCX1 myocytes, although the [Ca2+]o
effect was still significant (P < 0.0001).
|
|
|
|
Immunofluorescence localization of PLM and NCX1 in adult rat
myocytes.
The specificities of monoclonal anti-NCX1 antibody R3F1
(21) and polyclonal anti-PLM antibody (27)
have been detailed elsewhere. Under nonreducing conditions, R3F1
recognized a single band with an apparent molecular mass of 160 kDa in
rat myocytes homogenates (Fig. 5), which corresponded to NCX1
(20). The polyclonal antibodies raised against the
COOH-terminus of PLM recognized a single band with apparent molecular
mass of 15-16 kDa (Fig. 5), where native cardiac PLM was expected
to migrate on SDS-PAGE (2). Both PLM (Fig.
6A) and NCX1 (Fig.
6B) antibodies labeled adult rat ventricular myocytes
extensively in all regions exposed to the extracellular space: at the
sarcolemma, at intercalated disks, and in the transverse tubules (t
tubules). Images at different planes through the myocyte (0.25-µm
sections, ~85 sections/myocyte) were then deconvolved to remove
out-of-focus contaminating light to generate high-resolution images
(Fig. 6, D, E, G, and H).
These images from the centers of myocytes revealed similar features that were identified in the wide-field views (Fig. 6, A and
B). In particular, no specific label was detected in
intracellular structures or organelles. In addition, when the stacks of
PLM and NCX1 images were processed and merged (Fig. 6, F and
I), it is apparent that PLM and NCX1 colocalized to the same
areas of the myocyte. This is true whether PLM was detected with
FITC-labeled secondary antibody and NCX1 with Texas red-labeled
secondary antibody (Fig. 6, D-F) or whether PLM was
detected with Texas red-labeled secondary antibody and NCX1 with
FITC-labeled secondary antibody (Fig. 6, G-I).
|
| |
DISCUSSION |
|---|
|
|
|---|
PLM belongs to the FXYD gene family of small ion transport regulators (28). In noncardiac tissues, PLM has been shown to exhibit ion channel-like behavior (17), channel regulatory roles (26), and osmotic regulatory function (18). In adult rat cardiac myocytes, we have recently demonstrated that PLM overexpression resulted in altered contraction and [Ca2+]i transients, without affecting NCX1 and SR Ca2+-ATPase protein levels and SR Ca2+ uptake (27). The mechanisms by which PLM perturbed Ca2+ fluxes and contractile function, however, are not known. Because the pattern of contractile and [Ca2+]i transient abnormalities observed in PLM myocytes (amplitudes higher at 0.6 mM [Ca2+]o but lower at 5 mM [Ca2+]o) mimicked that observed in myocytes in which Na+/Ca2+ exchange activity was depressed (29, 31, 33) and was opposite to that observed in NCX1-overexpressed myocytes (32), we speculated that PLM might directly regulate Na+/Ca2+ exchange activity. Thus the first major finding of the present study is that PLM overexpression directly inhibited Na+/Ca2+ exchange activity, both in the forward mode (3 Na+ in:1 Ca2+ out), as indicated by prolonged relaxation from caffeine-induced contractures (Fig. 1), and in the reverse mode (3 Na+ out:1 Ca2+ in), as evidenced by reduced reverse INaCa (Fig. 2).
Our present INaCa values (measured at + 70 mV) in 3-day cultured myocytes were
59% lower when compared with
those previously measured in freshly isolated rat cardiac myocytes
(33). The differences may be due to the effects of
short-term culture, but more likely relate to the fact that we used a
more physiological but lower pipette [Na+] (12.5 vs. 25 mM) in the present experiments. The 28-33% difference in
INaCa between control GFP and PLM myocytes,
although modest, is likely to be physiologically relevant because
relaxation from caffeine-induced contracture was slower (Fig. 1) and
myocyte contraction was affected in PLM myocytes (Fig. 4 and Table 2).
In this context, the difference in INaCa between
GFP and PLM myocytes is in the same order of magnitude as that between
sham and postinfarction rat myocytes (
46%; Ref. 33);
the latter has been demonstrated to suffer from contraction
abnormalities and slowed relaxation from caffeine-induced contractures
(31).
In the present study, we confirmed our previous observation (27) that PLM overexpression resulted in increased contraction amplitude at 0.6 mM [Ca2+]o but decreased cell shortening at 5 mM [Ca2+]o (Fig. 4, A-D, and Table 2). Because depressed INaCa in PLM-overexpressed myocytes (Fig. 2) may alter AP morphology, the abnormal pattern of contraction in PLM myocytes could be due to AP changes rather than directly resulting from reduced NCX1 function. Thus a second major finding is that PLM overexpression did not affect RMP and AP morphology in adult rat myocytes (Fig. 3 and Table 1). In addition, the pattern of contractile abnormalities observed in PLM myocytes could be ameliorated by cooverexpression of NCX1 (Fig. 4 and Table 2), thereby providing additional support, albeit indirect, that PLM affected myocyte contractile function by modulating Na+/Ca2+ exchange activity.
In addition to thermodynamic parameters [intracellular ([Na+]i) and extracellular [Na+] ([Na+]o), [Ca2+]i, [Ca2+]o, and membrane potential) that regulate Na+/Ca2+ exchange activity, other known factors that enhance NCX1 activity include ATP/phosphatidyl inositol 4,5-bisphosphate, acidic phospholipids, phosphoarginine, and protein kinases A and C (1, 8, 10, 13). Inhibitory factors of NCX1 activity include extracellular [Mg2+], acidic pH, XIP peptide, sulfhydryl groups, and an unknown endogenous inhibitor of 350-550 kDa (1, 11, 15, 23). Our present results (Figs. 1, 2, and 4) indicate that one of the physiological functions of PLM in cardiac tissues is to modulate NCX1 activity. Our results, however, did not differentiate whether phosphorylated or dephosphorylated PLM is required for its inhibitory effects on NCX1 activity. On the basis of the observation that PLM phosphorylation in response to adrenergic stimulation paralleled the inotropic response (22), one may speculate that NCX1 activity is inhibited by PLM, with which, on phosphorylation of PLM by protein kinases A (16, 22) or C (30), the inhibitory effect is removed. In this light, it is interesting to note that enhanced NCX1 activity by protein kinase C (13) did not require direct phosphorylation of the NCX1 (12).
The mechanisms by which PLM inhibits NCX1 activity have not been
addressed in this study. Recent coimmunoprecipitation studies indicate
that PLM associates with
-isozymes of
Na+-K+-ATPase in bovine cardiac sarcolemma
(5). In addition, when coexpressed with rat
Na+-K+-ATPase (either
1-
1 or
2-
1
isozymes) in Xenopus oocytes, PLM effected a 1.5- to 2-fold
decrease in the apparent affinity of Na+-K+-ATPase for internal Na+
(5). Inhibition of Na+-K+-ATPase
by PLM would result in elevation in [Na+]i
and theoretically could modulate NCX1 activity indirectly. This
mechanism is unlikely to account for our experimental observations on
PLM myocytes for the following reasons. On the basis of thermodynamics considerations alone, increased [Na+]i should
diminish forward Na+/Ca2+ exchange
(Ca2+ efflux) but enhance reverse
Na+/Ca2+ exchange (Ca2+ influx).
This would result in increased contraction amplitudes in PLM myocytes
studied under both low (Ca2+ efflux promoting) and high
(Ca2+ influx promoting) [Ca2+]o
conditions, a prediction not consistent with our observations in PLM
myocytes (Fig. 4 and Table 2). In addition, under our whole cell
patch-clamp conditions, in which [Na+]i in
the well-dialyzed myocyte was likely to be "clamped" at pipette
[Na+] and Na+-K+-ATPase activity
would be minimal in the absence of K+ in both external and
pipette filling solutions, reverse INaCa was
still significantly lower in PLM than GFP myocytes (Fig. 2).
Another major finding of the present study is that PLM was detected only in the sarcolemma, intercalated disks, and t tubules (Fig. 6, A, D, and G). This, we believe, is the first report of PLM localization in cardiac tissues. We also confirmed previous reports (9, 14, 24) that NCX1 was localized to the t tubules and sarcolemma (Fig. 6, B, E, and H), although there is some controversy as to the relative distribution of NCX1 in adult myocytes (9, 14). More interestingly, the merged images (Fig. 6, C, F, and I) suggest colocalization of PLM and NCX1 to the same membrane regions of the myocyte, thus providing anatomic support for interactions between PLM and NCX1. We wanted to emphasize that immunofluorescence colocalization of two molecules does not prove direct interaction between the two molecules. Higher resolution techniques such as fluorescence resonance energy transfer and yeast two-hybrid systems are better suited to detect molecular interactions.
In myocytes isolated from rat hearts 3-8 wk after myocardial infarction (MI), both reverse INaCa (33) and Na+-dependent Ca2+ uptake in sarcolemmal vesicles (6) were depressed, and relaxation from caffeine-induced contracture was prolonged (31). In addition, when compared with myocytes isolated from sham-operated hearts, twitch amplitudes were higher at 0.6 mM [Ca2+]o but lower at 5 mM [Ca2+]o in post-MI myocytes (31). It has been shown that PLM expression was increased twofold post-MI (25). An interesting speculation is that at least some of the contractile abnormalities observed in post-MI myocytes is due to enhanced PLM expression, leading to increased inhibition of Na+/Ca2+ exchange activity, with resultant alteration in contractile function.
In summary, we have demonstrated direct inhibition of both forward and reverse Na+/Ca2+ exchange activity by PLM overexpression in adult rat myocytes. Contractile abnormalities in PLM myocytes were ameliorated by cooverexpression of NCX1. Immunofluorescence studies suggest colocalization of PLM and NCX1 to the sarcolemma, intercalated disks, and t-tubules. We conclude that PLM affects myocyte contractility by modulating Na+/Ca2+ exchanger function. We speculate that overexpression of PLM may partly account for contractile abnormalities in postinfarction myocytes.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Kristin Gaul for assistance in the preparation of the manuscript.
| |
FOOTNOTES |
|---|
* X.-Q. Zhang and A. Qureshi contributed equally to this work.
This study was supported in part by National Institutes of Health Grants HL-58672 (to J. Y. Cheung), DK-46678 (J. Y. Cheung), GM-46991 (to L. I. Rothblum), NS-21925, NS-37716, and NS-41363 (to D. J. Carey) and by grants from the Geisinger Foundation (to J. Y. Cheung, L. I. Rothblum, and D. J. Carey).
Address for reprint requests and other correspondence: J. Y. Cheung, Weis Center for Research, Geisinger Medical Center, Danville, PA 17822-2619 (E-mail: jcheung{at}geisinger.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published September 26, 2002;10.1152/ajpheart.00698.2002
Received 7 August 2002; accepted in final form 23 September 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Blaustein, MP,
and
Lederer WJ.
Sodium/calcium exchange: its physiological implications.
Physiol Rev
79:
763-854,
1999
2.
Chen, Z,
Jones LR,
O'Brian JJ,
Moorman JR,
and
Cala SE.
Structure domains in phospholemman: a possible role for the carboxyl terminus in channel inactivation.
Circ Res
82:
367-374,
1998
3.
Cheung, JY,
Musch TI,
Misawa H,
Semanchick A,
Elensky M,
Yelamarty RV,
and
Moore RL.
Impaired cardiac function in rats with healed myocardial infarction: cellular vs. myocardial mechanisms.
Am J Physiol Cell Physiol
266:
C29-C36,
1994
4.
Cheung, JY,
Thompson IG,
and
Bonventre JV.
Effects of extracellular calcium removal and anoxia on isolated rat myocytes.
Am J Physiol Cell Physiol
243:
C184-C190,
1982
5.
Crambert, G,
Fuzesi M,
Garty H,
Karlish S,
and
Geering K.
Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties.
Proc Natl Acad Sci USA
99:
11476-11481,
2002
6.
Dixon, IM,
Hata T,
and
Dhalla NS.
Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats.
Am J Physiol Heart Circ Physiol
262:
H1387-H1394,
1992
7.
Ellingsen, O,
Davidoff AJ,
Prasad SK,
Berger HJ,
Springhorn JP,
Marsh JD,
Kelly RA,
and
Smith TW.
Adult rat ventricular myocytes cultured in defined medium: phenotype and electromechanical function.
Am J Physiol Heart Circ Physiol
265:
H747-H754,
1993
8.
Fan, J,
Shuba YM,
and
Morad M.
Regulation of cardiac sodium-calcium exchanger by
-adrenergic agonists.
Proc Natl Acad Sci USA
93:
5527-5532,
1996
9.
Frank, JS,
Mottino G,
Reid D,
Molday RS,
and
Philipson KD.
Distribution of the Na+-Ca2+ exchange protein in mammalian cardiac myocytes: an immunofluorescence and immunocolloidal gold-labeling study.
J Cell Biol
117:
337-345,
1992
10.
Hale, CC,
Ebeling EG,
Hsu FF,
and
Ford DA.
The selective activation of the cardiac sarcolemmal sodium-calcium exchanger by plasmalogenic phospholipase D.
FEBS Lett
422:
247-251,
1998[Web of Science][Medline].
11.
Hiller, R,
Shpak C,
Shavit G,
Shpak B,
and
Khananshvili D.
An unknown endogenous inhibitor of Na/Ca exchange can enhance the cardiac muscle contractility.
Biochem Biophys Res Commun
277:
138-146,
2000[Web of Science][Medline].
12.
Iwamoto, T,
Pan Y,
Nakamura TY,
Wakabayashi S,
and
Shigakawa M.
Protein kinase C-dependent regulation of Na+/Ca2+ exchanger isoforms NCX1 and NCX3 does not require their direct phosphorylation.
Biochemistry
37:
17230-17238,
1998[Medline].
13.
Iwamoto, T,
Pan Y,
Wakabayashi S,
Imagawa T,
Yamanaka HI,
and
Shigakawa M.
Phosphorylation-dependent regulation of cardiac Na+/Ca2+ exchanger via protein kinase C.
J Biol Chem
271:
13609-13615,
1996
14.
Kieval, RS,
Bloch RJ,
Lindermayer GE,
Ambesi A,
and
Lederer WJ.
Immunofluorescence localization of the Na-Ca exchanger in heart cells.
Am J Physiol Cell Physiol
263:
C545-C550,
1992
15.
Li, ZP,
Nicoll DA,
Collins A,
Hilgemann DW,
Filoteo AG,
Penniston JT,
Weiss JN,
Tomich JM,
and
Philipson KD.
Identification of a peptide inhibitor of the cardiac sarcolemmal Na+/Ca2+ exchanger.
J Biol Chem
266:
1014-1020,
1991
16.
Lindemann, JP.
-Adrenergic stimulation of sarcolemmal protein phosphorylation and slow responses in intact myocardium.
J Biol Chem
261:
4860-4867,
1985
17.
Moorman, JR,
Ackerman SJ,
Kowdley GC,
Griffin MP,
Mounsey JP,
Chen Z,
Cala SE,
O'Brian JJ,
Szabo G,
and
Jones LR.
Unitary anion currents through phospholemman channel molecules.
Nature
377:
737-740,
1995[Medline].
18.
Moran, J,
Morales-Mulia M,
and
Pasantes-Morales H.
Reduction of phospholemman expression decreases osmosensitive taurine efflux in astrocytes.
Biochim Biophys Acta
1538:
313-320,
2001[Medline].
19.
Mounsey, JP,
John JE, III,
Helmke SM,
Bush EW,
Gilbert J,
Roses AD,
Perryman MB,
Jones LR,
and
Moorman JR.
Phospholemman is a substrate for myotonic dystrophy protein kinase.
J Biol Chem
275:
23362-23367,
2000
20.
Philipson, KD,
Longoni S,
and
Ward R.
Purification of the cardiac Na+-Ca2+ exchange protein.
Biochim Biophys Acta
945:
298-306,
1988[Medline].
21.
Porzig, H,
Li Z,
Nicoll DA,
and
Philipson KD.
Mapping of the cardiac sodium-calcium exchanger with monoclonal antibodies.
Am J Physiol Cell Physiol
265:
C748-C756,
1993
22.
Presti, CF,
Jones LR,
and
Lindemann JP.
Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium.
J Biol Chem
260:
3860-3867,
1985
23.
Ren, X,
Kasir J,
and
Rahamimoff H.
The transport activity of Na+-Ca2+ exchanger NCX1 expressed in HEK293 cells is sensitive to covalent modification of intracellular cysteine residues by sulfhydryl reagents.
J Biol Chem
276:
9572-9579,
2001
24.
Scriven, DRL,
Dan P,
and
Moore EDW
Distribution of proteins implicated in excitation-contraction coupling in rat ventricular myocytes.
Biophys J
79:
2682-2691,
2000[Web of Science][Medline].
25.
Sehl, PD,
Tai JTN,
Hillan KJ,
Brown LA,
Goddard A,
Yang R,
Jin H,
and
Lowe DG.
Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to inquiry.
Circulation
101:
1990-1999,
2000
26.
Shimbo, K,
Brassard DL,
Lamb RA,
and
Pinto LH.
Viral and small integral membrane proteins can modify ion channels endogenous to xenopus oocytes.
Biophys J
69:
1819-1829,
1995[Web of Science][Medline].
27.
Song, J,
Zhang XQ,
Carl LL,
Qureshi A,
Rothblum LI,
and
Cheung JY.
Overexpression of phospholemman alters contractility and [Ca2+]i transients in adult rat myocytes.
Am J Physiol Heart Circ Physiol
283:
H576-H583,
2002
28.
Sweadner, KJ,
and
Rael E.
The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression.
Genomics
68:
41-56,
2000[Web of Science][Medline].
29.
Tadros, GM,
Zhang XQ,
Song J,
Carl LL,
Rothblum LI,
Tian Q,
Dunn J,
Lytton J,
and
Cheung JY.
Effects of Na+/Ca2+ exchanger downregulation on contractility and [Ca2+]i transients in adult rat myocytes.
Am J Physiol Heart Circ Physiol
283:
H1616-H1626,
2002
30.
Waalas, O,
Horn RS,
and
Waalas SI.
Insulin and phorbol enter stimulate phosphorylation of a 15,000 dalton membrane protein in rat diaphragm in a similar manner.
Biochim Biophys Acta
1094:
92-102,
1991[Medline].
31.
Zhang, XQ,
Musch TI,
Zelis R,
and
Cheung JY.
Effects of impaired Ca2+ homeostasis on contraction in postinfarction myocytes.
J Appl Physiol
86:
943-950,
1999
32.
Zhang, XQ,
Song J,
Rothblum LI,
Lun M,
Wang X,
Ding F,
Dunn J,
Lytton J,
McDermott PJ,
and
Cheung JY.
Overexpression of Na+/Ca2+ exchanger alters contractility and SR Ca2+ content in adult rat myocytes.
Am J Physiol Heart Circ Physiol
281:
H2079-H2088,
2001
33.
Zhang, XQ,
Tillotson DL,
Moore RL,
Zelis R,
and
Cheung JY.
Na+/Ca2+ exchange currents and SR Ca2+ contents in postinfarction myocytes.
Am J Physiol Cell Physiol
271:
C1800-C1807,
1996
34.
Zhang, XQ,
Zhang LQ,
Palmer BM,
Ng YC,
Musch TI,
Moore RL,
and
Cheung JY.
Sprint training shortens prolonged action potential duration in postinfarction rat myocyte: mechanisms.
J Appl Physiol
90:
1720-1728,
2001
This article has been cited by other articles:
![]() |
W. Fuller, J. Howie, L. M. McLatchie, R. J. Weber, C. J. Hastie, K. Burness, D. Pavlovic, and M. J. Shattock FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1346 - C1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhang, J. Wang, L. L. Carl, J. Song, B. A. Ahlers, and J. Y. Cheung Phospholemman regulates cardiac Na+/Ca2+ exchanger by interacting with the exchanger's proximal linker domain Am J Physiol Cell Physiol, April 1, 2009; 296(4): C911 - C921. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, X.-Q. Zhang, J. Wang, E. Cheskis, T. O. Chan, A. M. Feldman, A. L. Tucker, and J. Y. Cheung Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+-K+-ATPase Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1615 - H1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Despa, A. L. Tucker, and D. M. Bers Phospholemman-Mediated Activation of Na/K-ATPase Limits [Na]i and Inotropic State During {beta}-Adrenergic Stimulation in Mouse Ventricular Myocytes Circulation, April 8, 2008; 117(14): 1849 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bell, E. Kennington, W. Fuller, K. Dighe, P. Donoghue, J. E. Clark, L.-G. Jia, A. L. Tucker, J. Randall Moorman, M. S. Marber, et al. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H613 - H621. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lubarski, S. J. D. Karlish, and H. Garty Structural and functional interactions between FXYD5 and the Na+-K+-ATPase Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1818 - F1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Han, J. Bossuyt, S. Despa, A. L. Tucker, and D. M. Bers Phospholemman Phosphorylation Mediates the Protein Kinase C-Dependent Effects on Na+/K+ Pump Function in Cardiac Myocytes Circ. Res., December 8, 2006; 99(12): 1376 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Tucker, J. Song, X.-Q. Zhang, J. Wang, B. A. Ahlers, L. L. Carl, J. P. Mounsey, J. R. Moorman, L. I. Rothblum, and J. Y. Cheung Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2199 - H2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Lansbery, L. C. Burcea, M. L. Mendenhall, and R. W. Mercer Cytoplasmic targeting signals mediate delivery of phospholemman to the plasma membrane Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1275 - C1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Geering FXYD proteins: new regulators of Na-K-ATPase Am J Physiol Renal Physiol, February 1, 2006; 290(2): F241 - F250. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhang, J. R. Moorman, B. A. Ahlers, L. L. Carl, D. E. Lake, J. Song, J. P. Mounsey, A. L. Tucker, Y.-m. Chan, L. I. Rothblum, et al. Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes J Appl Physiol, January 1, 2006; 100(1): 212 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reis, L. Zhang, S. Cala, K. N. Jew, L. C. Mace, L. Chung, R. L. Moore, and Y.-C. Ng Expression of phospholemman and its association with Na+-K+-ATPase in skeletal muscle: effects of aging and exercise training J Appl Physiol, October 1, 2005; 99(4): 1508 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Despa, J. Bossuyt, F. Han, K. S. Ginsburg, L.-G. Jia, H. Kutchai, A. L. Tucker, and D. M. Bers Phospholemman-Phosphorylation Mediates the {beta}-Adrenergic Effects on Na/K Pump Function in Cardiac Myocytes Circ. Res., August 5, 2005; 97(3): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, X.-Q. Zhang, B. A. Ahlers, L. L. Carl, J. Wang, L. I. Rothblum, R. C. Stahl, J. P. Mounsey, A. L. Tucker, J. R. Moorman, et al. Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2342 - H2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Jia, C. Donnet, R. C. Bogaev, R. J. Blatt, C. E. McKinney, K. H. Day, S. S. Berr, L. R. Jones, J. R. Moorman, K. J. Sweadner, et al. Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1982 - H1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mirza, X.-Q. Zhang, B. A. Ahlers, A. Qureshi, L. L. Carl, J. Song, A. L. Tucker, J. P. Mounsey, J. R. Moorman, L. I. Rothblum, et al. Effects of phospholemman downregulation on contractility and [Ca2+]i transients in adult rat cardiac myocytes Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1322 - H1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Blalock, K.-C. Chen, K. Sharrow, J. P. Herman, N. M. Porter, T. C. Foster, and P. W. Landfield Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment J. Neurosci., May 1, 2003; 23(9): 3807 - 3819. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |